Capecitabine

Symptoms / Indications

• Colorectal cancer
• Breast cancer
• Gastric cancer
• Metastatic cancer conditions
• Tumor progression
• Cancer-related complications

Product Overview

Capecitabine is an oral antineoplastic agent widely used in oncology for the treatment of several cancers, including colorectal, breast, and gastric cancers. It belongs to the class of antimetabolite chemotherapeutic agents and is designed to selectively target tumor cells. Capecitabine is converted into its active form, 5-fluorouracil (5-FU), within the body, enabling targeted action against cancer cells while minimizing systemic exposure.

This formulation offers the advantage of oral administration, improving patient convenience and compliance compared to intravenous chemotherapy. Manufactured under stringent quality standards, Capecitabine is suitable for hospitals, oncology centers, and pharmaceutical distributors. It is an essential product in oncology portfolios and meets international quality and export requirements.

Therapeutic Category

Anticancer / Antineoplastic Agent

Dosage Form

Capsules

Mechanism of Action

Capecitabine is an antimetabolite prodrug that is converted in the body to 5-fluorouracil (5-FU). It interferes with DNA synthesis by inhibiting thymidylate synthase, an enzyme required for DNA replication. This action prevents the growth and multiplication of cancer cells, ultimately leading to cell death. Its targeted activation within tumor tissues enhances its therapeutic effect.

Dosage & Administration

Capecitabine should be taken strictly as prescribed by a qualified oncologist. It is usually administered orally with water within 30 minutes after a meal. The dosage and treatment duration depend on the type and severity of cancer. Do not exceed the prescribed dose, as improper use may lead to serious side effects.

Side Effects

• Nausea
• Vomiting
• Diarrhea
• Fatigue

Precautions & Warnings

Use under strict medical supervision, especially in oncology settings. Caution is required in patients with liver or kidney impairment. Regular monitoring of blood counts and organ function is recommended during treatment. Avoid self-medication and ensure proper dosing to prevent toxicity.

Drug Interactions

Capecitabine may interact with anticoagulants, antacids, and other chemotherapeutic agents, potentially altering its effectiveness or increasing toxicity. Patients should inform their healthcare provider about all medications being taken.

Pregnancy & Breastfeeding

Pregnancy: Consult doctor before use
Breastfeeding: Consult doctor before use

Storage

Store in a cool, dry place below 25°C, away from sunlight and moisture. Keep out of reach of children.

Shelf Life

24 months

Quality & Compliance

This product is manufactured in a WHO-GMP compliant facility following stringent quality control standards. Each batch is tested for safety, efficacy, and stability. It is suitable for global markets with complete export documentation and regulatory support.

Business Opportunity

Allotab Healthcare is a leading pharmaceutical manufacturer and exporter operating from a WHO-GMP and EU-GMP certified facility in India, ensuring the highest standards of quality and compliance. We offer a wide range of pharmaceutical formulations including tablets, capsules, injections, ointments, oral liquids, and advanced molecules, catering to diverse therapeutic segments. Our portfolio also includes a comprehensive range of oncology products, supporting global healthcare needs. With strong manufacturing capabilities, regulatory expertise, and reliable supply, Allotab Healthcare serves distributors, hospitals, and healthcare organizations across international markets.

We offer reliable bulk supply of Capecitabine for oncology distributors and healthcare institutions. Custom packaging, competitive pricing, and export support are available to meet international requirements.

Disclaimer

This information is for informational purposes only. Use under medical supervision.